Morgan Stanley 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-05 4:14 pm Sale | 2026-05-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | MORGAN STANLEY MS | 0 0.000% | -9,592,751 (Position Closed) | Filing |
| 2025-02-03 1:09 pm Purchase | 2024-12-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | MORGAN STANLEY MS | 9,592,751 7.700% | 9,592,751 (New Position) | Filing |